| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/02/2002 | CA2133203C Hybrid human/porcine factor viii |
| 07/02/2002 | CA2109601C Amide derivatives of antibiotic a 40926 |
| 07/02/2002 | CA2083172C Protein d - an igd-binding protein of haemophilus influenzae |
| 07/02/2002 | CA2082960C An apparatus for preparing a concentrate of coagulation factors, such as fibrinogen, from a blood sample |
| 07/02/2002 | CA2080008C Water-soluble mutein of fibroblast growth factor (fgf) receptor |
| 07/02/2002 | CA2073486C Composition for the prevention of lyme disease and use for |
| 07/02/2002 | CA2054699C Growth of vascular endothelial cell growth factor and dna encoding same |
| 07/02/2002 | CA2050749C Nucleotide sequence coding for an outer membrane protein from neisseria meningitidis and use of said protein in vaccine preparations |
| 07/02/2002 | CA2047792C Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines |
| 07/02/2002 | CA2032527C Lytic peptides: their use in the treatment of microbial infections, cancer and in the promotion of growth |
| 07/02/2002 | CA1341372C Hybrid dna synthesis of insulin |
| 06/27/2002 | WO2002050545A2 Compositions and methods involving staphylococcus aureus protein staau-r9 |
| 06/27/2002 | WO2002050303A2 Protein-protein interactions |
| 06/27/2002 | WO2002050302A2 Protein-protein interactions |
| 06/27/2002 | WO2002050300A2 Human hyperpolarization-activated cyclic nucleotide-gated cation channel hcn3 |
| 06/27/2002 | WO2002050295A2 Arcelin-5 promoter and uses thereof |
| 06/27/2002 | WO2002050293A2 Plants with improved resistance |
| 06/27/2002 | WO2002050292A2 Modulation of plant cyclin-dependent kinase inhibitor activity |
| 06/27/2002 | WO2002050289A1 Methods for the production of multimeric proteins, and related compositions |
| 06/27/2002 | WO2002050287A2 Multifunctional protease inhibitors and their use in treatment of disease |
| 06/27/2002 | WO2002050281A1 Virus resistance in plants |
| 06/27/2002 | WO2002050279A2 Nucleic acid-associated proteins |
| 06/27/2002 | WO2002050278A2 Novel human secreted proteins and polynucleotides encoding the same |
| 06/27/2002 | WO2002050277A2 Protein and nucleic acids encoding same |
| 06/27/2002 | WO2002050276A2 Proteins and nucleic acids encoding same |
| 06/27/2002 | WO2002050275A2 Proteins and nucleic acids encoding same |
| 06/27/2002 | WO2002050274A2 Seleno-cysteine containing protein zsel1 |
| 06/27/2002 | WO2002050273A2 A transmembrane protein as a downstream target of neurotrophin and ephrin receptor tyrosine kinases, dna encoding same monoclonal antibodies thereto |
| 06/27/2002 | WO2002050272A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 06/27/2002 | WO2002050271A2 Human ion channel protein and polynucleotides encoding the same |
| 06/27/2002 | WO2002050270A1 Novel tissue-specific secretory polypeptide and dna thereof |
| 06/27/2002 | WO2002050269A1 Method of examining allergic disease |
| 06/27/2002 | WO2002050266A1 Novel g protein-coupled receptor protein and dna thereof |
| 06/27/2002 | WO2002050265A1 Novel transmembrane receptor-like proteins and dnas thereof |
| 06/27/2002 | WO2002050262A2 Mutant mycobacteria for use in therapy |
| 06/27/2002 | WO2002050261A2 PROTEINS THAT INTERACT WITH βTRCP |
| 06/27/2002 | WO2002050250A2 Signal-1/signal-2 bifunctional peptide inhibitors |
| 06/27/2002 | WO2002050249A2 Protein-protein interactions |
| 06/27/2002 | WO2002050122A2 Means for the diagnosis and therapy of ctcl |
| 06/27/2002 | WO2002050119A2 Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 06/27/2002 | WO2002050117A2 G-proteins coupled receptor proteins and nucleic acids encoding same |
| 06/27/2002 | WO2002050116A2 Adhesion molecule protein |
| 06/27/2002 | WO2002050115A1 Modified tachykinin receptors |
| 06/27/2002 | WO2002050114A2 Modulation of atp-binding cassette transporter activity |
| 06/27/2002 | WO2002050113A2 Interleukin-1 related gene and protein |
| 06/27/2002 | WO2002050112A2 Isolation of purified tgf- 1 and tgf- 2 from bone tissue |
| 06/27/2002 | WO2002050111A2 Isolated laminin 10 |
| 06/27/2002 | WO2002050110A1 Novel gene encoding an f-box protein which regulates leaf longevity in arabidopsis thaliana and mutant gene thereof |
| 06/27/2002 | WO2002050108A2 Immunogenic glycopeptides, screening, preparation and uses |
| 06/27/2002 | WO2002050107A2 Streptococcus pyogenes antigens and corresponding dna fragments |
| 06/27/2002 | WO2002050106A2 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r4 |
| 06/27/2002 | WO2002050105A1 Novel compounds |
| 06/27/2002 | WO2002050104A2 Methods and cells for detecting modulators of rgs proteins |
| 06/27/2002 | WO2002050103A2 Tumour-related antigens |
| 06/27/2002 | WO2002050101A1 Retinoblastoma-binding protein |
| 06/27/2002 | WO2002050098A2 Haplotypes of the prlr gene |
| 06/27/2002 | WO2002050097A2 Anti-allergic complex molecules |
| 06/27/2002 | WO2002050096A1 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 06/27/2002 | WO2002049677A1 Lentiviral vector-mediated gene transfer and uses thereof |
| 06/27/2002 | WO2002049671A1 Recombinant serum albumin for use in cleansing or dermatological products for skin or hair |
| 06/27/2002 | WO2002049625A2 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds |
| 06/27/2002 | WO2002049423A1 Joint utilization of the insulin gene and the glucokinase gene in the development of therapeutic approaches for diabetes mellitus |
| 06/27/2002 | WO2002049422A2 Non-human animal disease models |
| 06/27/2002 | WO2002026994A8 Manipulation of plant cell walls |
| 06/27/2002 | WO2002026935A3 TGF-β INHIBITORS AND METHODS |
| 06/27/2002 | WO2002020822A3 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 06/27/2002 | WO2002020721A3 Vectors derived from south african arbovirus no. 86 |
| 06/27/2002 | WO2002020566A3 NOVEL MMP-2 DERIVATIVES FOR USE AS INHIBITORS OF INTEGRIN αVβ¿3? |
| 06/27/2002 | WO2002016548A3 Novel g protein-coupled receptor |
| 06/27/2002 | WO2002016439A8 Novel nucleic acids and polypeptides |
| 06/27/2002 | WO2002016433A3 Two receptors of meiosis activating sterols designated sam1a and sam1b |
| 06/27/2002 | WO2002016415A3 Identification of a cam-kinase ii inhibitor |
| 06/27/2002 | WO2002012543A3 Two coloured fluorimetric protease assay |
| 06/27/2002 | WO2002012540A3 Reaper protein |
| 06/27/2002 | WO2002012291A3 Novel nucleotide sequences coding for the luxr gene and a process for the production of l-amino acids |
| 06/27/2002 | WO2002008279A3 B7-h2 molecules, novel members of the b7 family and uses thereof |
| 06/27/2002 | WO2002006487A3 Regulatory sequences from meristematic cells |
| 06/27/2002 | WO2002005844A3 Protein complex serving as a vehicle for orally administerable medicaments |
| 06/27/2002 | WO2002004601A3 Mammalian mdm2 binding proteins and uses thereof |
| 06/27/2002 | WO2002002597A3 Peptide extended glycosylated polypeptides |
| 06/27/2002 | WO2002000882A3 Transport peptides dirived from erns protein, cytotoxic rnase of ribosome-inactivating protein or a rsv g-protein and analogues thereof |
| 06/27/2002 | WO2001098536A3 METHOD FOR ACTIVATING PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-$g(g) |
| 06/27/2002 | WO2001094583A3 Human transporter proteins and polynucleotides encoding the same |
| 06/27/2002 | WO2001094570A3 Transfection method |
| 06/27/2002 | WO2001087938A3 Polynucleotide sequence encoding a putative cell adhesion molecule |
| 06/27/2002 | WO2001085949A3 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| 06/27/2002 | WO2001083746A3 Regulatory nucleic acid sequences of the abc1 gene |
| 06/27/2002 | WO2001081426A3 Rgd (arg-gly-asp) coupled to (neuro)peptides |
| 06/27/2002 | WO2001081370A3 Histone h2a-derived peptides useful in gene delivery |
| 06/27/2002 | WO2001081361B1 Compositions and method for diagnosing and treating conditions, disorders, or diseases involving cell death |
| 06/27/2002 | WO2001077375A3 Diagnosis of diseases associated with gene regulation |
| 06/27/2002 | WO2001076457A3 Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death |
| 06/27/2002 | WO2001075086A3 Multi-domain proteinase inhibitor |
| 06/27/2002 | WO2001074849A3 Binding peptides for carcinoembryonic antigen (cea) |
| 06/27/2002 | WO2001073027A3 Compositions and methods for therapy and diagnosis of colon cancer |
| 06/27/2002 | WO2001073025A3 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains |
| 06/27/2002 | WO2001072994A3 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof |
| 06/27/2002 | WO2001072827A3 33395, a human leucine-rich repeat family member and use thereof |
| 06/27/2002 | WO2001070987A3 Novel inflorescence meristem development gene, promoter, and methods of use for same |
| 06/27/2002 | WO2001070978A3 Polypeptides and nucleic acids encoding same |